Zum Hauptinhalt springen

Affinity Biotech

affinity

Founded in 2006, Affinity Biosciences is a pioneering Life Science and High-Tech company whose biochemical products and services are mainly applied in biotechnology, medical research and pharmaceutical development.

Dedicating to advancing customer success through innovation, Affinity Biosciences has established R&D affiliates in the United Kingdom and United States with the aim of providing outstanding service around the globe.Our customers include scientists and technologists in life science companies, university and government institutions, hospitals and industry. To underline our commitment to our customers and enhance our standards of service, we have opened packaging and quality control facilities in the People’s Republic of China. Our goal is to develop high-quality antibody that focuses on Cell Signaling Transduction research, including Akt,AMPK,NF-KappaB,TGF-beta,etc,as well as inhibitors and related reagents.

www.affbiotech.com

The prices are on request! Contact Us by e-mail info@divbio.de

Heterophilic antibody blocker for BEK-2226 & BEK-2218 and similar ELISA assays-1000 µg BL-003-1000



Der In den Warenkorb Knopf erscheint sobald die obigen Werte ausgewählt wurden

Spezifikationen

1000 µg
BL-003-1000 contains a proprietary mixture of proteins and buffer reagents designed to reduce heterophilic interactions in ELISA assays utilizing a combination of sheep and mouse immunoreagents.

Following ELISA assays in the Biosensis RapidTM ELISA range have been validated to achieve accurate results using BL-003-1000:

BEK-2226, Human proNGF; Application: Serum, Heparin-Plasma
BEK-2218, Human NT4/5; Application: Citrate-Plasma

One vial of BL-003-1000 contains 1000 μg IgG which is sufficient as sample diluent additive for one 96-well plate.

Other ELISA assays that use sheep and mouse assay antibodies may also benefit from addition of blocker BL-003-1000, but require optimization of working concentration and assay validation for accurate results.